Last reviewed · How we verify

NCT07377422

Safety and Efficacy of a Novel Composite-Tip Guiding Catheter in Transcarotid Artery Stenting Via Transradial Access

Not yet recruiting NA Last updated 29 January 2026
What this trial tests

NA trial testing Composite-Tip Transradial Neurovascular Distal Access Catheter in Transradial Carotid Artery Stenting in 204 participants. Not yet recruiting.

Timeline
19 January 2026
Primary endpoint
16 June 2027
16 August 2027

Quick facts

Lead sponsorBeijing Anzhen Hospital
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment204
Start date19 January 2026
Primary completion16 June 2027
Estimated completion16 August 2027
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Beijing Anzhen Hospital

Who can join

18 and older, any sex, with Transradial Carotid Artery Stenting or Novel Composite-tip Guiding Catheter. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the safety and efficacy of the novel composite-tip guiding catheter for transradial access in Carotid Artery Stenting procedures

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Beijing Anzhen Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07377422.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing